Möchten Sie immer auf dem neuesten Stand bleiben?

Patients treated with Cylembio (imsapepimut and etimupepimut, adjuvanted) plus pembrolizumab achieved improvement in progression free survival (PFS) compared to patients treated with pembrolizumab...

Sheridan will temporarily step aside as CEO to enter the Irish Presidential Election. Company Chairman and President, Serguei Melnik will take over as interim CEO over the course of the...

FDA granted meeting request

Stock dividend issued to IMUNON shareholders reflects confidence in clinical programs, long-term growth strategy and dedication to rewarding shareholders First patient dosed in Phase 3 OVATION 3...

SAB BIO Announces Oversubscribed $175 Million Private Placement

Highlights Mineral Processing optimization tests underway Multiple parallel avenues of testing in progress with the objective of increasing overall magnet rare earths recoveries Long lead time...

New York, June 05, 2025 (GLOBE NEWSWIRE) -- Huma Therapeutics, the global healthcare AI company, today announced the launch of Hi Scribe, a generative AI clinical documentation tool designed to...

Annamycin delivering better performance 7th line than would be expected even in 2nd line for monotherapy Responders (Stable Disease or Partial Response) after 2 cycles of Annamycin showed...

Luton, Bedfordshire, United Kingdom, June 03, 2025 (GLOBE NEWSWIRE) -- Market Overview The global Diagnostic Imaging Clinical Trials Market was valued at USD 12 billion in 2024 and is projected to...

PharmAla makes shipment to Yale, Agrees with Multidisciplinary Association for Psychedelic Studies to publicly post Investigator's Brochure for LaNeo MDMA